AzTrials
AzTrials

StrokeNCT03067818

Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis

A study testing Unaffected Transcranial Magnetic Stimulation and Affected Transcranial Magnetic Stimulation in people with Stroke and Hemiparesis, run by George Mason University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study examines the effect of non-invasive brain stimulation targeting different brain areas on movement of the affected arm post-stroke. Participants will receive stimulation to each of 3 different brain areas combined with a session of arm exercise. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Stroke, Hemiparesis, Cerebral Vascular Accident
What is being tested?
Unaffected Transcranial Magnetic Stimulation and Affected Transcranial Magnetic Stimulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
20 Jun 2017to 28 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • More than 6 months post-stroke
  • Loss of voluntary finger movement in the affected hand
  • Some voluntary movement of affected shoulder and/or elbow

Who cannot join

  • Brainstem or cerebellar stroke
  • Severe cognitive or language deficits
  • Epilepsy or other seizure disorder
  • Central nervous system disease or disorder other than stroke

Trial locations and contacts

1 site in 1 country.

United States1 site
  • MedStar National Rehabilitation Hospital

    Washington D.C., District of Columbia, 20010

Other trials in United States

About this study

This study examines the effect of non-invasive brain stimulation targeting different brain areas on movement of the affected arm post-stroke. Participants will receive stimulation to each of 3 different brain areas combined with a session of arm exercise.

Read the detailed description

Small improvements in affected arm movement can be made with intensive physical practice. These improvements could potentially be enhanced by combining non-invasive brain stimulation with practice.

To develop such an intervention, it is necessary to understand which brain areas should be stimulated in which types of patients. It is probably more beneficial to target one side of the brain vs. the other, for example, depending on the characteristics of the stroke.

This study will examine the effect of stimulating one side of the brain vs. the other on the amount of improvement that occurs from physically practicing functional arm movements.

Being tested
Unaffected Transcranial Magnetic Stimulation, Affected Transcranial Magnetic Stimulation, Control Transcranial Magnetic Stimulation
Keywords
arm, rehabilitation, non-invasive brain stimulation, transcranial magnetic stimulation, upper extremity
Medical subject headings
Stroke, Paresis, Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Unaffected Transcranial Magnetic StimulationProcedure or surgery

    Non-invasive brain stimulation to unaffected hemisphere site prior to practice

  • Affected Transcranial Magnetic StimulationProcedure or surgery

    Non-invasive brain stimulation to affected hemisphere site prior to practice

  • Control Transcranial Magnetic StimulationProcedure or surgery

    Non-invasive brain stimulation to control site prior to practice

Study groups in NCT03067818
Study groupRoleWhat they receive
Unaffected HemisphereExperimentalApplication of "Unaffected Transcranial Magnetic Stimulation" to unaffected hemisphere site prior to physical practice
Receives: Procedure: Unaffected Transcranial Magnetic Stimulation
Affected HemisphereExperimentalApplication of "Affected Transcranial Magnetic Stimulation" to affected hemisphere site prior to physical practice
Receives: Procedure: Affected Transcranial Magnetic Stimulation
Control SiteActive comparatorApplication of "Control Transcranial Magnetic Stimulation" to control site prior to practice
Receives: Procedure: Control Transcranial Magnetic Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in movement time

    Percentage change in time it takes to move the arm a standardized distance

    Measured: Baseline and 1 Day

Secondary outcomes (2)
  1. Change in maximum reaching distance

    Percentage change in maximum distance participant is able to reach

    Measured: Baseline and 1 Day

  2. Change in hand path kinematics

    Percentage change in temporal and spatial movement of the hand during reaching

    Measured: Baseline and 1 Day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Mar 2017
  2. Study start20 Jun 2017
  3. Primary completion15 Aug 2019
  4. Study completion28 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will receive stimulation targeting each brain area. The order in which the stimulation sites are targeted for each participant is randomized and there is a washout period of several weeks between each treatment.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03067818
Sponsor's protocol ID
1R21HD090516-01
Status last verified
Sep 2019
First submitted
24 Feb 2017
Last updated
11 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Unaffected Transcranial Magnetic Stimulation and Affected Transcranial Magnetic Stimulation in people with Stroke and Hemiparesis, run by George Mason University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in movement time (time frame: Baseline and 1 Day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in